These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6414221)

  • 1. Activation of plasma fibrinolysis after intrarectal administration of high molecular weight urokinase and its derivative.
    Sumi H; Maruyama M; Yoneta T; Mihara H
    Acta Haematol; 1983; 70(5):289-95. PubMed ID: 6414221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma fibrinolysis after intraduodenal administration of urokinase in rats.
    Sumi H; Seiki M; Morimoto N; Tsushima H; Maruyama M; Mihara H
    Enzyme; 1985; 33(3):122-7. PubMed ID: 4054071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-like plasminogen activator increased in plasma after alcohol drinking.
    Sumi H; Hamada H; Tsushima H; Mihara H
    Alcohol Alcohol; 1988; 23(1):33-43. PubMed ID: 3128990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of wine on plasma fibrinolytic and coagulation systems.
    Sumi H; Kozaki Y; Yatagai C; Hamada H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 1998 Jun; 33(3):263-72. PubMed ID: 9702004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A low molecular weight urokinase derivative with enhanced fibrin affinity.
    Chen XC; Hua ZC; Zhu DX
    Biochem Mol Biol Int; 1996 Jul; 39(4):797-803. PubMed ID: 8843349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental studies on the mode and amount of urokinase administration in thrombolytic therapy (author's transl)].
    Matsuo O; Mihara H
    Rinsho Ketsueki; 1977 Sep; 18(9):1097-101. PubMed ID: 592505
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhanced thrombolysis in plasma and in vivo by single-chain urokinase-type plasminogen activator (scuPA) conjugated to an antifibrin antibody.
    Bode C; Runge M; Eberle T; Freitag M; Kübler W; Haber E
    Trans Assoc Am Physicians; 1989; 102():7-12. PubMed ID: 2517856
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activator.
    Stassen JM; Juhan-Vague I; Alessi MC; De Cock F; Collen D
    Thromb Haemost; 1987 Oct; 58(3):947-50. PubMed ID: 2829381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--IV. Variability in fibrinolytic response of plasma of several mammalian species.
    Lijnen HR; De Wreede K; Demarsin E; Collen D
    Thromb Haemost; 1984 Aug; 52(1):31-3. PubMed ID: 6495261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a "single shot" of urokinase on fibrinolytic activities in patients with IgA nephropathy.
    Tomino Y; Miura M; Suga T; Yagame M; Endoh M; Nomoto Y; Sakai H; Itoh K; Ikeda N
    Tokai J Exp Clin Med; 1984 Mar; 9(1):43-7. PubMed ID: 6535301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal polypeptide (VIP) stimulates fibrinolytic system in the rat.
    Hagiwara M; Hongo K; Morikawa T
    Jpn J Pharmacol; 1990 Sep; 54(1):86-8. PubMed ID: 2273652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrin-binding urokinase (or precursor form of urokinase) with a molecular weight of about 100,000 in fresh human urine.
    Sumi H; Tsushima H; Maruyama M; Mihara H
    Enzyme; 1985; 34(4):201-11. PubMed ID: 2941273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary prourokinase.
    Wojta J; Kirchheimer JC; Turcu L; Christ G; Binder BR
    Thromb Haemost; 1986 Jun; 55(3):347-51. PubMed ID: 3092391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elastase digested urokinase (ED-UK).
    Sumi H; Kosugi T; Toki N; Mihara H
    Experientia; 1985 Dec; 41(12):1546-8. PubMed ID: 3852742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilized procedure for the determination of urokinase fibrinolytic potency.
    Sutherland JW; Banick DW; Schmakel CO
    Anal Biochem; 1991 Apr; 194(1):121-9. PubMed ID: 1867376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapleural activation, processing, efficacy, and duration of protection of single-chain urokinase in evolving tetracycline-induced pleural injury in rabbits.
    Idell S; Allen T; Chen S; Koenig K; Mazar A; Azghani A
    Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L25-32. PubMed ID: 16980376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pro-urokinase and urokinase on the fibrinolytic system in man.
    Trübestein G; Popov S; Wolf H; Welzel D
    Haemostasis; 1987; 17(4):238-44. PubMed ID: 2442078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral urokinase: absorption, mechanisms of fibrinolytic enhancement and clinical effect on cerebral thrombosis.
    Abe T
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):122-36. PubMed ID: 2427393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.